Alejandro Sepulveda

Alejandro Sepulveda

Company: Janssen

Job title: Scientific Director, Head of Cancer Vaccines


Development of a First-in-class Shared Neo-Antigen Vaccine for the Treatment of Prostate Cancer 2:45 pm

• Data to show critical understanding of the tumor microenvironment to determine response to immune checkpoint therapy in combination with cancer vaccines • Identification of VISTA as a potent inhibitory checkpoint that is predominantly expressed on CD68+ macrophages on PDACs, suggesting that VISTA may be a relevant immunotherapy target for effective treatment of patients with…Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.